← All trials
NCT06472661
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 30, 2024
- Primary completion
- Aug 31, 2026
- Completion date
- Aug 31, 2026
- First posted
- Jun 25, 2024
- Last posted
- Sep 19, 2024
- Enrollment
- 11
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of VirginiaLead sponsor
- University of VirginiaSponsor investigator
- University of VirginiaOfficial
- TheraclionCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.